(0.10%) 5 522.25 points
(0.12%) 39 893 points
(0.22%) 19 794 points
(-0.01%) $81.62
(0.57%) $2.83
(-0.30%) $2 337.30
(-0.02%) $29.52
(0.25%) $1 004.30
(-0.01%) $0.931
(-0.05%) $10.53
(-0.01%) $0.788
(-0.85%) $87.25
0.67% $ 4.48
Live Chart Being Loaded With Signals
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 383 395 |
Średni wolumen | 572 874 |
Kapitalizacja rynkowa | 277.11M |
EPS | $-0.380 ( Q1 | 2024-05-07 ) |
Następna data zysków | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.32 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00900 (0.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Mathers Edward T | Buy | 28 000 | Stock Option (right to buy) |
2024-06-18 | Hopfner Robert Lorne | Buy | 28 000 | Stock Option (right to buy) |
2024-06-18 | Diaz Reinaldo M | Buy | 28 000 | Stock Option (right to buy) |
2024-06-18 | Sullivan Lynne Marie | Buy | 28 000 | Stock Option (right to buy) |
2024-06-18 | Bhagat Sarah M | Buy | 28 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
97.92 |
Last 96 transactions |
Buy: 15 798 930 | Sell: 20 219 419 |
Wolumen Korelacja
Inozyme Pharma, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
KOD | 0.855 |
MNDY | 0.845 |
VXRT | 0.84 |
RPRX | 0.839 |
SVRE | 0.827 |
FGEN | 0.826 |
PXLW | 0.826 |
ROST | 0.824 |
PFF | 0.823 |
ACLX | 0.823 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Inozyme Pharma, Inc. Korelacja - Waluta/Towar
Inozyme Pharma, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.29M (0.00 %) |
EPS: | $-1.370 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.29M (0.00 %) |
EPS: | $-1.370 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.18M (0.00 %) |
EPS: | $-1.730 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.40 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Inozyme Pharma, Inc.
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej